Literature DB >> 31728847

Identification of tumor residuals in pituitary adenoma surgery with intraoperative MRI: do we need gadolinium?

Georg Gohla1, Benjamin Bender2, Marcos Tatagiba3, Jürgen Honegger3, Ulrike Ernemann1, Constantin Roder3.   

Abstract

OBJECTIVE: To evaluate the diagnostic accuracy of high-resolution T2w intraoperative magnetic resonance imaging (iMRI) for detecting pituitary adenoma remnants compared to contrast-enhanced T1-weighted images.
METHODS: 42 patients underwent iMRI-guided resection of large pituitary macroadenomas and fulfilled the inclusion criteria for this retrospective analysis. Intraoperative and postoperative imaging evaluation of tumor residuals and localization were assessed by two experienced neuroradiologists in a blinded fashion. The diagnostic accuracy of T2w and contrast-enhanced T1w images were evaluated.
RESULTS: The diagnostic accuracy for detecting tumor residuals of high-resolution T2w images showed highly significant association to contrast-enhanced T1w images (p < 0.0001). Furthermore, identification rate of tumor remnants in different compartments, e.g., cavernous sinus, was comparable. In total, coronal T2w images provided a diagnostic sensitivity of 97.7% and specificity of 100% compared to the gold standard of contrast-enhanced T1w images. The postoperatively expected extent of resection proved to be true in 97.6% according to MRI 3 months after resection.
CONCLUSIONS: High-resolution T2w intraoperative MR images provide excellent diagnostic accuracy for detecting tumor remnants in macroadenoma surgery with highly significant association compared to T1w images with gadolinium. The routine-use and need of gadolinium in these patients should be questioned critically in each case in the future.

Entities:  

Keywords:  Gadolinium; High-resolution MRI; Intraoperative MRI; Pituitary adenoma

Mesh:

Substances:

Year:  2019        PMID: 31728847     DOI: 10.1007/s10143-019-01202-4

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  21 in total

1.  A mobile high-field magnetic resonance system for neurosurgery.

Authors:  G R Sutherland; T Kaibara; D Louw; D I Hoult; B Tomanek; J Saunders
Journal:  J Neurosurg       Date:  1999-11       Impact factor: 5.115

Review 2.  Intraoperative MR imaging guidance for intracranial neurosurgery: experience with the first 200 cases.

Authors:  R B Schwartz; L Hsu; T Z Wong; D F Kacher; A A Zamani; P M Black; E Alexander; P E Stieg; T M Moriarty; C A Martin; R Kikinis; F A Jolesz
Journal:  Radiology       Date:  1999-05       Impact factor: 11.105

3.  Comparing 0.2 tesla with 1.5 tesla intraoperative magnetic resonance imaging analysis of setup, workflow, and efficiency.

Authors:  Christopher Nimsky; Oliver Ganslandt; Rudolf Fahlbusch
Journal:  Acad Radiol       Date:  2005-09       Impact factor: 3.173

Review 4.  Intraoperative magnetic resonance imaging during surgery for pituitary adenomas: pros and cons.

Authors:  Michael Buchfelder; Sven-Martin Schlaffer
Journal:  Endocrine       Date:  2012-07-26       Impact factor: 3.633

5.  Intraoperative high-field magnetic resonance imaging in transsphenoidal surgery of hormonally inactive pituitary macroadenomas.

Authors:  Christopher Nimsky; Boris von Keller; Oliver Ganslandt; Rudolf Fahlbusch
Journal:  Neurosurgery       Date:  2006-07       Impact factor: 4.654

6.  Determining the utility of intraoperative magnetic resonance imaging for transsphenoidal surgery: a retrospective study.

Authors:  Jan Coburger; Ralph König; Klaus Seitz; Ute Bäzner; Christian Rainer Wirtz; Michal Hlavac
Journal:  J Neurosurg       Date:  2013-12-13       Impact factor: 5.115

7.  Intraoperative high-field-strength MR imaging: implementation and experience in 200 patients.

Authors:  Christopher Nimsky; Oliver Ganslandt; Boris Von Keller; Johann Romstöck; Rudolf Fahlbusch
Journal:  Radiology       Date:  2004-08-18       Impact factor: 11.105

Review 8.  Intraoperative magnetic resonance imaging in pituitary macroadenoma surgery: an assessment of visual outcome.

Authors:  Jesse Jones; John Ruge
Journal:  Neurosurg Focus       Date:  2007       Impact factor: 4.047

9.  Feasibility of Polestar N20, an ultra-low-field intraoperative magnetic resonance imaging system in resection control of pituitary macroadenomas: lessons learned from the first 40 cases.

Authors:  Ruediger Gerlach; Richard du Mesnil de Rochemont; Thomas Gasser; Gerhard Marquardt; Juergen Reusch; Lioba Imoehl; Volker Seifert
Journal:  Neurosurgery       Date:  2008-08       Impact factor: 4.654

10.  Impact of intraoperative MRI-guided transsphenoidal surgery on endocrine function and hormone substitution therapy in patients with pituitary adenoma.

Authors:  David Bellut; Martin Hlavica; Carl Muroi; Christoph M Woernle; Christoph Schmid; René L Bernays
Journal:  Swiss Med Wkly       Date:  2012-10-23       Impact factor: 2.193

View more
  2 in total

Review 1.  Impact of intraoperative magnetic resonance imaging on gross total resection, extent of resection, and residual tumor volume in pituitary surgery: systematic review and meta-analysis.

Authors:  Victor E Staartjes; Alex Togni-Pogliorini; Vittorio Stumpo; Carlo Serra; Luca Regli
Journal:  Pituitary       Date:  2021-05-04       Impact factor: 4.107

2.  The value of intraoperative MRI for resection of functional pituitary adenomas-a critical assessment of a consecutive single-center series of 114 cases.

Authors:  Christopher Beynon; Andreas Unterberg; Moritz Scherer; Paul Zerweck; Daniela Becker; Lars Kihm; Jessica Jesser
Journal:  Neurosurg Rev       Date:  2022-05-14       Impact factor: 2.800

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.